This review discussed the proposed mechanism of action of epicutaneous immunotherapy (EPIT) in both rodents and humans. EPIT is a method that delivers peanut allergen through the skin in order to induce tolerance to the allergen. Authors also looked at efficacy and safety data from clinical trials with peanut EPIT, and discussed its potential role in the future management of peanut allergy.
